WO1997007139A3 - Stabilized chitin derivative compounds - Google Patents

Stabilized chitin derivative compounds Download PDF

Info

Publication number
WO1997007139A3
WO1997007139A3 PCT/EP1996/003474 EP9603474W WO9707139A3 WO 1997007139 A3 WO1997007139 A3 WO 1997007139A3 EP 9603474 W EP9603474 W EP 9603474W WO 9707139 A3 WO9707139 A3 WO 9707139A3
Authority
WO
WIPO (PCT)
Prior art keywords
polysaccharide
stabilized
chitin derivative
derivative compounds
solution
Prior art date
Application number
PCT/EP1996/003474
Other languages
French (fr)
Other versions
WO1997007139A2 (en
Inventor
Shau-Fong Yen
Mary Sou
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/675,748 external-priority patent/US5773608A/en
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Priority to AU67426/96A priority Critical patent/AU6742696A/en
Publication of WO1997007139A2 publication Critical patent/WO1997007139A2/en
Publication of WO1997007139A3 publication Critical patent/WO1997007139A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Abstract

A process for sterilizing a polysaccharide composition containing chitosan, a chitosan derivative or a chitin derivative without substantially degrading the polysaccharide. The process has the steps of blending the polysaccharide in a solvent to form a solution or suspension; sterilizing the solution or suspension; dissolving suspended particles, if present; and then aseptically adjusting the pH of the sterilized solution. There is additionally provided a polyol stabilizing agent suitable for the polysaccharide composition.
PCT/EP1996/003474 1995-08-17 1996-08-06 Stabilized chitin derivative compounds WO1997007139A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU67426/96A AU6742696A (en) 1995-08-17 1996-08-06 Stabilized chitin derivative compounds

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US51642095A 1995-08-17 1995-08-17
US08/516,420 1995-08-17
US08/675,748 US5773608A (en) 1995-08-17 1996-07-03 Process for preparing stabilized chitin derivative compounds
US08/675,748 1996-07-03

Publications (2)

Publication Number Publication Date
WO1997007139A2 WO1997007139A2 (en) 1997-02-27
WO1997007139A3 true WO1997007139A3 (en) 1997-04-10

Family

ID=27058839

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1996/003474 WO1997007139A2 (en) 1995-08-17 1996-08-06 Stabilized chitin derivative compounds

Country Status (2)

Country Link
AU (1) AU6742696A (en)
WO (1) WO1997007139A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005030011A1 (en) * 2005-06-17 2006-12-21 Aesculap Ag & Co. Kg Process for the preparation of sterile polysaccharide solutions
WO2016066195A1 (en) * 2014-10-29 2016-05-06 Laboratoire Medidom Sa Heat-sterilized formulation comprising chitosan and process of preparation thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0180934A2 (en) * 1984-11-06 1986-05-14 DECHEMA Deutsche Gesellschaft für Chemisches Apparatewesen, Chemische Technik und Biotechnologie e.V. Use of coarse granules of layered silicates as adsorbents for proteins
GB2179043A (en) * 1985-08-09 1987-02-25 British Food Manufacturing Ind Foamed products
EP0356060A2 (en) * 1988-08-18 1990-02-28 Minnesota Mining And Manufacturing Company Wound filling compositions
WO1994007999A1 (en) * 1992-09-28 1994-04-14 Brown University Research Foundation Chitosan matrices for encapsulated cells
US5422116A (en) * 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
EP0665022A1 (en) * 1994-01-28 1995-08-02 Prodex, Inc. Viscoelastic solution of N,O-carboxymethyl chitosan for ophthalmic use

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0180934A2 (en) * 1984-11-06 1986-05-14 DECHEMA Deutsche Gesellschaft für Chemisches Apparatewesen, Chemische Technik und Biotechnologie e.V. Use of coarse granules of layered silicates as adsorbents for proteins
GB2179043A (en) * 1985-08-09 1987-02-25 British Food Manufacturing Ind Foamed products
EP0356060A2 (en) * 1988-08-18 1990-02-28 Minnesota Mining And Manufacturing Company Wound filling compositions
WO1994007999A1 (en) * 1992-09-28 1994-04-14 Brown University Research Foundation Chitosan matrices for encapsulated cells
EP0665022A1 (en) * 1994-01-28 1995-08-02 Prodex, Inc. Viscoelastic solution of N,O-carboxymethyl chitosan for ophthalmic use
US5422116A (en) * 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system

Also Published As

Publication number Publication date
WO1997007139A2 (en) 1997-02-27
AU6742696A (en) 1997-03-12

Similar Documents

Publication Publication Date Title
AU6789796A (en) Compositions including o-carboxyalkyl chitosan and methods of use in ophthalmics
GB2344519B (en) Sterile therapeutic compositions
EP0905289A3 (en) Antibacterial cellulose fiber and production process thereof
AUPN969796A0 (en) Taste masked liquid suspensions
CA2146938A1 (en) Method of Controlling Structure Stability of Collagen Fibers Produced from Solutions or Dispersions Treated with Sodium Hydroxide for Infectious Agent Deactivation
HUP9800688A3 (en) Complex of gamma-cyclodextrin and retinol or retinol derivatives, process for their production and cosmetic an pharmaceutical compositions containing them
CA2089430A1 (en) Aqueous pharmaceutical suspension for pharmaceutical active
AU4789696A (en) Oral dosage-forms containing a beta -lactam antibiotic
HUT62198A (en) Erythropoietin compositions comprising cyclodextrin
AU7408991A (en) Aqueous cosmetic or dermo-pharmaceutical composition containing, in suspension, hydrated spheroids of a hydrophilic lipidic substance
HUP9901153A3 (en) Azetidinone derivatives for the treatment of atherosclerosis, their production and pharmaceutical compositions containing them
HUT68239A (en) Process for producing inclusion complexes of nimesulide alkali salts with cyclodextrins or cyclodextrin derivatives and pharmaceutical preparations containing them
HU9402292D0 (en) New baccatine-iii and 10-deacetyl-baccatine-iii derivatives, process for producing them and pharmaceutical compositions containing them as active component
AU7239794A (en) Process for preparing 5,8-dihydronaphthoquinone derivatives, novel 5,8-dihydronaphthoquinone derivatives and their use as anticancer agent
WO1997007139A3 (en) Stabilized chitin derivative compounds
EP0717992A3 (en) Aqueous suspension formulations for pharmaceutical applications
CA2048047A1 (en) Succinoglycane composition
EP0475383A3 (en) Polysaccharide composition or polysaccharide having heparinoid activity, process for producing the same, and anticoagulant containing the same as active ingredient
AU6551198A (en) Novel benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them
CA2173403A1 (en) External Therapeutic Composition for Dermatitis
CA2370294A1 (en) Haze-free cellulose ether capsules and process for making
CA2173642A1 (en) Process for Derivatizing Polyglucosamines
AU668788B2 (en) Chitosan derivatives, preparation process thereof and cosmetic compositions containing same
EP1059304A4 (en) Novel polysaccharide derivatives, process for the production thereof and medicinal compositions containing the same as the active ingredient
WO1996041646A3 (en) Pharmaceutical compositions containing lornoxicam and cyclodextrin

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AU BB BG BR CA CN CU CZ EE GE HU IL IS JP KP KR LK LR LT LV MG MK MN MX NO NZ PL RO SG SI SK TR TT UA UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AU BB BG BR CA CN CU CZ EE GE HU IL IS JP KP KR LK LR LT LV MG MK MN MX NO NZ PL RO SG SI SK TR TT UA UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA